DuPont de Nemours (NYSE:DD) Stock Price Expected to Rise, UBS Group Analyst Says

DuPont de Nemours (NYSE:DD) had its price target boosted by equities research analysts at UBS Group from $175.00 to $178.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the basic materials company’s stock. UBS Group’s target price would suggest a potential upside of 21.01% from the stock’s previous close.

A number of other brokerages also recently issued reports on DD. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of DuPont de Nemours in a report on Monday. Deutsche Bank Aktiengesellschaft increased their price target on shares of DuPont de Nemours from $174.00 to $180.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Royal Bank Of Canada lifted their target price on DuPont de Nemours from $168.00 to $180.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Morgan Stanley boosted their price target on shares of DuPont de Nemours from $132.00 to $156.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 28th. Finally, Bank of America dropped their price objective on DuPont de Nemours from $150.00 to $141.00 and set a “neutral” rating on the stock in a report on Tuesday, April 21st. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, DuPont de Nemours currently has an average rating of “Moderate Buy” and an average target price of $165.40.

DuPont de Nemours Stock Up 2.9%

DD traded up $4.16 during trading hours on Wednesday, hitting $147.09. 1,512,574 shares of the company’s stock were exchanged, compared to its average volume of 1,455,918. The firm has a market cap of $19.86 billion, a P/E ratio of -817.10, a price-to-earnings-growth ratio of 1.33 and a beta of 1.06. The company has a current ratio of 2.68, a quick ratio of 2.11 and a debt-to-equity ratio of 0.22. DuPont de Nemours has a 12-month low of $87.26 and a 12-month high of $157.98. The firm has a 50 day moving average of $139.65 and a 200 day moving average of $140.31.

DuPont de Nemours (NYSE:DD) last released its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.76 by $0.12. The firm had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.81 billion. DuPont de Nemours had a positive return on equity of 7.15% and a negative net margin of 0.30%.DuPont de Nemours’s revenue was up 4.0% compared to the same quarter last year. During the same period last year, the business posted $1.12 earnings per share. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. Analysts predict that DuPont de Nemours will post 7.16 EPS for the current fiscal year.

Institutional Investors Weigh In On DuPont de Nemours

Several hedge funds have recently made changes to their positions in the business. Contravisory Investment Management Inc. acquired a new stake in DuPont de Nemours in the 2nd quarter worth about $74,000. Elevation Wealth Partners LLC grew its stake in DuPont de Nemours by 168.5% during the second quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock worth $32,000 after buying an additional 150 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab acquired a new stake in DuPont de Nemours in the 2nd quarter valued at $2,800,000. Redwood Investment Management LLC purchased a new stake in shares of DuPont de Nemours during the 1st quarter valued at about $1,049,000. Finally, NewEdge Advisors LLC raised its stake in shares of DuPont de Nemours by 130.2% during the first quarter. NewEdge Advisors LLC now owns 101,257 shares of the basic materials company’s stock valued at $4,638,000 after purchasing an additional 57,269 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

Key Headlines Impacting DuPont de Nemours

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: Q2 results exceeded expectations: DuPont reported adjusted EPS of $1.88 versus the $1.76 consensus estimate, while revenue rose 4% year over year to $1.82 billion, slightly ahead of forecasts. Healthcare, industrial water and aerospace demand helped support organic sales growth. DuPont Reports Second Quarter 2026 Results
• Positive Sentiment: Full-year outlook raised: The company said pricing actions, productivity improvements and stronger key markets should produce faster second-half growth. DuPont also plans to repurchase $250 million of shares in the third quarter, potentially supporting per-share results. DD Q2 Earnings Call Points to Faster Second-Half Growth
• Positive Sentiment: Cash generation was solid: DuPont produced $400 million of operating cash flow and $326 million of transaction-adjusted free cash flow, representing 127% conversion, giving it flexibility for buybacks and strategic investment. DuPont Reports Second Quarter 2026 Results
• Neutral Sentiment: DuPont is exploring potential acquisitions in the water and healthcare markets. Such deals could expand growth opportunities, although they may also increase execution and integration risks. DuPont says it is exploring M&A opportunities in water and healthcare
• Neutral Sentiment: New Corian Design distribution arrangements and recognition for its FilmTec water-treatment membrane improve commercial visibility, but are unlikely to materially affect near-term earnings. DuPont Strengthens Corian Design Distribution Network
• Negative Sentiment: Near-term guidance trails consensus: DuPont forecast third-quarter adjusted EPS of $1.80–$1.90 and revenue of roughly $1.8 billion, below analyst expectations of $1.93 EPS and $1.9 billion revenue. This could limit upside despite the raised annual outlook.

About DuPont de Nemours

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.